Long pentraxin 3: A marker of inflammation in untreated psoriatic patients

  • Authors:
    • Valentina Bevelacqua
    • Massimo Libra
    • Maria C. Mazzarino
    • Pietro Gangemi
    • Giuseppina Nicotra
    • Salvatore Curatolo
    • Daniela Massimino
    • Antonio Plumari
    • Paola Merito
    • Guido Valente
    • Franca Stivala
    • Stefano La Greca
    • Grazia Malaponte
  • View Affiliations

  • Published online on: September 1, 2006     https://doi.org/10.3892/ijmm.18.3.415
  • Pages: 415-423
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Psoriasis is a common cutaneous disorder characterized by abnormal epidermal differentiation, proliferation and inflammation mediated by dermal infiltrates, such as T cells, neutrophils, dendritic cells and macrophages. There are renewed interest in the role of components of the innate immune system. Cytokines such as tumor necrosis factor-α (TNF-α) and interleukin (IL)-6, and -1β involved in pathogenic phenomena in psoriasis are known as inducers of the acute phase response. Among the large group of acute phase reactants, C-reactive protein (CRP) and fibrinogen are of special interest in psoriasis. The PTX-3, a long pentraxin sharing similarities with the classical short proteins. Thus, considering the numerous biological roles of inflammatory cytokines and their relationship with inflammatory markers, such as CRP and fibrinogen we have investigated the role of PTX3 in psoriasis. To this aim PTX3, TNF-α, IL-6 and IL-1β in plasma and in monocytic cultures by enzyme linked immunosorbent assay (ELISA) in 44 patients including severe and mild psoriasis were measured. An increased production of PTX3, both in supernatant of purified monocytes and in plasma from patients with severe psoriasis, was found. The significant correlation, between cellular production and plasma levels of PTX3 in psoriasis was found as a sign of cellular activation by monocytes/macrophages that first infiltrate the psoriatic lesion. In severe psoriasis, a significant correlation between psoriasis area and severity index (PASI) score and TNF-α and IL-6 levels in both supernatant of monocytes and plasma was found. In contrast, no correlation was found for IL-1β. By immunohistochemistry and immunofluorescence, a strong PTX3 staining in fibroblasts, endothelial cells and monocytes/macrophages in severe psoriatic lesional skin was detected. Finally, a positive correlation between PTX3 and disease activity of psoriasis was observed as PASI score was elevated. These findings suggest that PTX3 could be used as a further marker of disease activity of psoriasis.

Related Articles

Journal Cover

September 2006
Volume 18 Issue 3

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Bevelacqua V, Libra M, Mazzarino MC, Gangemi P, Nicotra G, Curatolo S, Massimino D, Plumari A, Merito P, Valente G, Valente G, et al: Long pentraxin 3: A marker of inflammation in untreated psoriatic patients. Int J Mol Med 18: 415-423, 2006
APA
Bevelacqua, V., Libra, M., Mazzarino, M.C., Gangemi, P., Nicotra, G., Curatolo, S. ... Malaponte, G. (2006). Long pentraxin 3: A marker of inflammation in untreated psoriatic patients. International Journal of Molecular Medicine, 18, 415-423. https://doi.org/10.3892/ijmm.18.3.415
MLA
Bevelacqua, V., Libra, M., Mazzarino, M. C., Gangemi, P., Nicotra, G., Curatolo, S., Massimino, D., Plumari, A., Merito, P., Valente, G., Stivala, F., La Greca, S., Malaponte, G."Long pentraxin 3: A marker of inflammation in untreated psoriatic patients". International Journal of Molecular Medicine 18.3 (2006): 415-423.
Chicago
Bevelacqua, V., Libra, M., Mazzarino, M. C., Gangemi, P., Nicotra, G., Curatolo, S., Massimino, D., Plumari, A., Merito, P., Valente, G., Stivala, F., La Greca, S., Malaponte, G."Long pentraxin 3: A marker of inflammation in untreated psoriatic patients". International Journal of Molecular Medicine 18, no. 3 (2006): 415-423. https://doi.org/10.3892/ijmm.18.3.415